Selective PPAR modulators, dual and pan PPAR agonists: multimodal drugs for the treatment of Type 2 diabetes and atherosclerosis
Year: 2006
Type: review
Source: Expert Opinion on Emerging Drugs
Institutions: Inserm, Université de Lille, Institut Pasteur de Lille
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2118763228
